Market Forecast By Procedure Type (Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis), By Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Single-Nucleotide Polymorphism), By Product and Services (Reagents and Consumables, Instruments, Software and Services), By End User (Maternity Centers, Fertility Clinics, Hospitals, Diagnostic Labs, Service Providers, Research Laboratories, Academic Institutes), By Test Type (Chromosomal Abnormalities, X-linked Diseases, Embryo Testing, Aneuploidy Screening, HLA Typing, Other), By Application (Embryo HLA Typing for Stem Cell Therapy, IVF Prognosis, Late Onset Genetic Disorders, Inherited Genetic Disease, Others) And Competitive Landscape
| Product Code: ETC6016128 | Publication Date: Sep 2024 | Updated Date: Dec 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
According to 6Wresearch internal database and industry insights, the Afghanistan Preimplantation Genetic Screening (PGS) Technology Market is projected to grow at a compound annual growth rate (CAGR) of 7.4% during the forecast period (2026 2032).
Below mentioned are the evaluation of years-wise growth rate along with key growth drivers:
| Year | CAGR (%) | Growth Drivers |
| 2021 | 2.5 | Growing awareness of hereditary disorders and infertility issues |
| 2022 | 3.3 | Rising demand for fertility treatments and assisted reproduction services |
| 2023 | 4.2 | Increasing availability of IVF clinics and diagnostic labs offering PGS/PGD services |
| 2024 | 5.1 | Improvement in laboratory infrastructure and access to genetic testing tools |
| 2025 | 6 | Rising demand for genetic disease prevention and family planning services |
Afghanistan Preimplantation Genetic Screening (PGS) Technology Market report thoroughly covers the market by procedure type, technology, product & services, end users, test type, and application. The market report provides an unbiased and detailed analysis of ongoing market trends, opportunities/high growth areas, and market drivers, which help stakeholders devise and align their market strategies according to the current and future market dynamics.
| Report Name | Egypt Yarn MarketAfghanistan Preimplantation Genetic Screening (PGS) Technology Market |
| Forecast period | 2026 2032 |
| CAGR | 7.4% |
| Growing Sector | Fertility Clinics & Diagnostic Labs |
Afghanistan Preimplantation Genetic Screening (PGS) Technology Market is expected to register substantial growth due to increasing awareness about genetic disorders, rising demand for assisted reproductive technologies (ART), and improving access to genetic testing facilities. Growing preference among couples for healthy offspring, coupled with expanding fertility clinics and diagnostic laboratories, is driving demand for PGS/PGD procedures. Support from international health organizations and improved laboratory infrastructure is contributing to adoption of advanced genetic screening technologies across the country.
Below mentioned are some prominent drivers and their influence to the market dynamics:
| Drivers | Primary Segments Affected | Why it Matters (Evidence) |
| Rising awareness of hereditary disorders | Test Type; Fertility Clinics & Diagnostic Labs | Increased concern about genetic diseases prompts couples to seek screening before embryo implantation. |
| Growth in fertility treatments and IVF procedures | Procedure Type; Fertility Clinics & Maternity Centers | Expansion in IVF usage supports higher demand for PGS/PGD services. |
| Improvement in laboratory and diagnostic infrastructure | Technology & Instruments; Diagnostic Labs & Research Laboratories | Access to modern genetic testing platforms enables accurate screening and diagnosis. |
| Availability of advanced genetic testing technologies | Technology & Software; Diagnostic Labs & Fertility Clinics | Use of NGS, PCR and other methods increase reliability and acceptance of PGS services. |
| Support from international health bodies and NGOs | End Users; Research Laboratories & Academic Institutes | Collaborative programs help establish genetic counselling, screening centers, and training for specialists. |
Afghanistan Preimplantation Genetic Screening (PGS) Technology Market is expected to grow at the CAGR of 7.4% during the forecast period of 2026 2032. Growth is driven by rising demand for genetic screening, improved laboratory infrastructure, and increased access to advanced genetic testing technologies supported by international collaborations.
Below mentioned are some major restraints and their influence to the market dynamics:
| Restraints | Primary Segments Affected | What This Means (Evidence) |
| High cost of genetic testing procedures | Procedure Type & Test Type; Fertility Clinics & Diagnostic Labs | Expense may limit adoption among low- and middle-income groups. |
| Limited number of trained genetic counsellors and lab specialists | All Technology Types; Fertility Clinics & Research Laboratories | Scarcity of skilled workforce delays establishment of quality screening services. |
| Low awareness about PGS/PGD among general population | End Users; Couples & Patients | The demand from public is low which reduces market growth potential. |
| Lack of regulatory framework for genetic testing and embryo screening | Application & End Users; Hospitals & Clinics | Improper formal guidelines may deter standardized adoption. |
| Limited access in rural and remote regions | End Users; Diagnostic Labs & Service Providers | Infrastructure and logistics constraints restrict availability outside major urban centres. |
Despite enormous growth and development, there are major hinderances to the Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Growth which includes high costs of tests, lack of trained geneticists and laboratory specialists, and low public awareness about genetic screening benefits. Apart from this, the absence of robust regulatory policies for embryo screening, lack of standardization in testing procedures, and inadequate outreach into rural or remote areas, which restrict broader market penetration further hampers growth to a major extent.
There are various emerging trends shaping the landscape of Afghanistan Preimplantation Genetic Screening (PGS) Technology Market:
Some prominent investment opportunities in the Afghanistan Preimplantation Genetic Screening (PGS) Technology Market include:
Some of the leading companies operating in the Afghanistan Preimplantation Genetic Screening (PGS) Technology Market are:
| Company Name | Illumina, Inc. |
|---|---|
| Established Year | 1998 |
| Headquarters | San Diego, USA |
| Official Website | Click Here |
Illumina is a leading provider of next-generation sequencing platforms and reagents extensively used for preimplantation genetic screening worldwide.
| Company Name | Thermo Fisher Scientific Inc. |
|---|---|
| Established Year | 1956 |
| Headquarters | Waltham, USA |
| Official Website | Click Here |
Thermo Fisher offers PCR kits, consumables, and instruments needed for PGS/PGD, supporting fertility clinics and diagnostic labs.
| Company Name | Myriad Genetics, Inc. |
|---|---|
| Established Year | 1991 |
| Headquarters | Utah, USA |
| Official Website | Click Here |
Myriad Genetics provides genetic diagnostic services and software for analyzing embryo genetic data, facilitating detection of inherited conditions.
| Company Name | CooperSurgical, Inc. |
|---|---|
| Established Year | 2005 |
| Headquarters | New Jersey, USA |
| Official Website | Click Here |
CooperSurgical supplies instruments, workflow solutions, and consumables for IVF clinics performing PGS/PGD procedures.
| Company Name | Ferring Pharmaceuticals |
|---|---|
| Established Year | 1950 |
| Headquarters | Saint Prex, Switzerland |
| Official Website | Click Here |
Ferring supports fertility treatments and collaborates with clinics offering PGS/PGD services to enhance success rates for in vitro fertilization procedures.
According to Afghan Government Data, there are several initiatives aimed at improving maternal and reproductive health services in Afghanistan. For example, the Reproductive Health Improvement Program supports establishment of fertility and diagnostic clinics in major urban centres, encouraging adoption of assisted reproductive technologies. Apart from this, the Ministry of Public Health has launched awareness campaigns on hereditary disorders and family planning which promotes genetic counseling and early diagnosis. Besides, granting tax exempt status for imported genetic testing equipment and reagents, making PGS/PGD services more affordable and accessible to private clinics and labs.
In the future years, the outlook for the Afghanistan Preimplantation Genetic Screening (PGS) Technology Market is expected to remain optimistic owing to increasing awareness of genetic diseases, intensifying demand for fertility services, and rising investments in diagnostic infrastructure. Apart from this, scaling up genetic counseling, integrating fertility and genetic diagnostics centers, and building local supply capabilities for reagents and consumables will drive market expansion. Besides, development of regulatory guidelines for genetic screening and support from international health bodies will further strengthen market maturity.
The report offers a comprehensive study of the subsequent market segments and their leading categories.
According to Saurabh, Senior Research Analyst, 6Wresearch, Preimplantation Genetic Screening (PGS) holds the largest market share because of its wide use for screening embryos for chromosomal abnormalities and improving IVF success rates. Couples seeking healthy offspring prefer PGS for general screening rather than waiting for diagnosis of known inherited diseases.
In terms of technology, the Next Generation Sequencing (NGS) is expected to dominate the Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Share in the future years due to its high accuracy, comprehensive detection capabilities, and growing affordability.
Within Products and Services, Reagents and Consumables are projected to hold the largest share as these are recurrent needs for each PGS/PGD cycle. High frequency of embryo testing and genetic screening drives consistent demand for consumables such as kits, reagents, culture media, and disposable labware.
Fertility Clinics are anticipated to dominate due to their core role in offering IVF combined with PGS/PGD services. As demand for reproductive services increases, clinics become primary end users providing integrated fertility and genetic screening solutions.
Under Application, IVF Prognosis is projected to dominate as PGS/PGD is primarily used to improve success rates of in vitro fertilization by selecting genetically healthy embryos. This application remains the key driver for adoption of PGS technologies in Afghanistan.
The report offers a comprehensive study of the subsequent market segments:
| 1 Executive Summary |
| 2 Introduction |
| 2.1 Key Highlights of the Report |
| 2.2 Report Description |
| 2.3 Market Scope & Segmentation |
| 2.4 Research Methodology |
| 2.5 Assumptions |
| 3 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Overview |
| 3.1 Afghanistan Country Macro Economic Indicators |
| 3.2 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, 2022 & 2032F |
| 3.3 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market - Industry Life Cycle |
| 3.4 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market - Porter's Five Forces |
| 3.5 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Procedure Type, 2022 & 2032F |
| 3.6 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Technology, 2022 & 2032F |
| 3.7 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Product and Services, 2022 & 2032F |
| 3.8 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By End User, 2022 & 2032F |
| 3.9 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Test Type, 2022 & 2032F |
| 3.10 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Application, 2022 & 2032F |
| 4 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Dynamics |
| 4.1 Impact Analysis |
| 4.2 Market Drivers |
| 4.2.1 Increasing awareness and acceptance of preimplantation genetic screening (PGS) technology in Afghanistan |
| 4.2.2 Growing demand for fertility treatments and assisted reproductive technologies in the country |
| 4.2.3 Advancements in genetic testing technologies and increasing focus on preventing genetic disorders in pregnancies |
| 4.3 Market Restraints |
| 4.3.1 Limited access to advanced healthcare facilities and technologies in remote regions of Afghanistan |
| 4.3.2 Cultural and ethical considerations surrounding the use of genetic screening technologies |
| 4.3.3 High cost associated with PGS procedures and lack of insurance coverage for such services |
| 5 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Trends |
| 6 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market, By Types |
| 6.1 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market, By Procedure Type |
| 6.1.1 Overview and Analysis |
| 6.1.2 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Procedure Type, 2022- 2032F |
| 6.1.3 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Preimplantation Genetic Screening, 2022- 2032F |
| 6.1.4 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Preimplantation Genetic Diagnosis, 2022- 2032F |
| 6.2 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market, By Technology |
| 6.2.1 Overview and Analysis |
| 6.2.2 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Next-Generation Sequencing, 2022- 2032F |
| 6.2.3 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Polymerase Chain Reaction, 2022- 2032F |
| 6.2.4 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Fluorescence in Situ Hybridization, 2022- 2032F |
| 6.2.5 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Comparative Genomic Hybridization, 2022- 2032F |
| 6.2.6 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Single-Nucleotide Polymorphism, 2022- 2032F |
| 6.3 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market, By Product and Services |
| 6.3.1 Overview and Analysis |
| 6.3.2 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Reagents and Consumables, 2022- 2032F |
| 6.3.3 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Instruments, 2022- 2032F |
| 6.3.4 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Software and Services, 2022- 2032F |
| 6.4 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market, By End User |
| 6.4.1 Overview and Analysis |
| 6.4.2 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Maternity Centers, 2022- 2032F |
| 6.4.3 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Fertility Clinics, 2022- 2032F |
| 6.4.4 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Hospitals, Diagnostic Labs, 2022- 2032F |
| 6.4.5 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Service Providers, 2022- 2032F |
| 6.4.6 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Research Laboratories, 2022- 2032F |
| 6.4.7 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Academic Institutes, 2022- 2032F |
| 6.5 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market, By Test Type |
| 6.5.1 Overview and Analysis |
| 6.5.2 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Chromosomal Abnormalities, 2022- 2032F |
| 6.5.3 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By X-linked Diseases, Embryo Testing, 2022- 2032F |
| 6.5.4 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Aneuploidy Screening, 2022- 2032F |
| 6.5.5 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By HLA Typing, 2022- 2032F |
| 6.5.6 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Other, 2022- 2032F |
| 6.6 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market, By Application |
| 6.6.1 Overview and Analysis |
| 6.6.2 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Embryo HLA Typing for Stem Cell Therapy, 2022- 2032F |
| 6.6.3 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By IVF Prognosis, 2022- 2032F |
| 6.6.4 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Late Onset Genetic Disorders, 2022- 2032F |
| 6.6.5 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Inherited Genetic Disease, 2022- 2032F |
| 6.6.6 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Others, 2022- 2032F |
| 7 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Import-Export Trade Statistics |
| 7.1 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Export to Major Countries |
| 7.2 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Imports from Major Countries |
| 8 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Key Performance Indicators |
| 8.1 Number of healthcare providers offering PGS services in Afghanistan |
| 8.2 Adoption rate of PGS technology among fertility clinics and patients |
| 8.3 Success rate of PGS procedures in terms of detecting genetic abnormalities |
| 8.4 Number of research studies and publications highlighting the benefits of PGS in Afghanistan |
| 8.5 Patient satisfaction and feedback on the effectiveness of PGS technology |
| 9 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market - Opportunity Assessment |
| 9.1 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Procedure Type, 2022 & 2032F |
| 9.2 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Technology, 2022 & 2032F |
| 9.3 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Product and Services, 2022 & 2032F |
| 9.4 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By End User, 2022 & 2032F |
| 9.5 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Test Type, 2022 & 2032F |
| 9.6 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Application, 2022 & 2032F |
| 10 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market - Competitive Landscape |
| 10.1 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Revenue Share, By Companies, 2022-232F |
| 10.2 Afghanistan Preimplantation Genetic Screening (PGS) Technology Market Competitive Benchmarking, By Operating and Technical Parameters |
| 11 Company Profiles |
| 12 Recommendations |
| 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here